Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO)

Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO)

Despite the abundance of data concerning biologic treatments for patients with psoriasis, clinicians are often challenged with discerning the optimal treatment for each patient. To inform this selection, this study explored whether a patient’s baseline characteristics or disease profile could predic...

Full description

Bibliographic Details
Main Authors: April W. Armstrong, Elisabeth Riedl, Patrick M. Brunner, Stefano Piaserico, Willie I. Visser, Natalie Haustrup, Bruce W. Konicek, Zbigniew Kadziola, Mercedes Nunez, Alan Brnabic, Christopher Schuster
Format: Article
Language:English
Published: Medical Journals Sweden 2024-09-01
Series:Acta Dermato-Venereologica
Subjects:
Psoriasis
biologics
treatment
nail psoriasis
pasi100
Online Access:https://medicaljournalssweden.se/actadv/article/view/40556

Internet

https://medicaljournalssweden.se/actadv/article/view/40556

Similar Items